This bill aims to enhance consumer transparency by establishing clear labeling requirements for cell-cultivated protein products and plant-based alternative protein products. It amends the Federal Meat Inspection Act, the Poultry Products Inspection Act, and the Federal Food, Drug, and Cosmetic Act to define these new food categories and mandate specific disclosures on their packaging. The goal is to ensure consumers can make informed decisions when choosing between these products and traditional meat and poultry. For cell-cultivated protein products , the bill requires labels to prominently state "cell-cultivated" and include disclaimers indicating they are not derived from naturally produced meat or poultry from live animals. Similarly, plant-based alternative protein products must be labeled with that phrase and a disclaimer clarifying they do not contain naturally produced meat or poultry. These provisions ensure that the origin of the product is immediately clear to the consumer. Furthermore, the legislation mandates a revision of the Memorandum of Understanding between the Secretary of Agriculture (USDA) and the Secretary of Health and Human Services (HHS) within 90 days to clarify their respective regulatory responsibilities for cell-cultivated protein products. The FDA will oversee premarket consultation, cell collection, cell bank development, and cell proliferation up to harvest, ensuring compliance with manufacturing practices and safety standards. The USDA will then be responsible for implementing the Act's amendments and applying existing meat and poultry inspection requirements to cell-cultivated protein products post-harvest. Finally, the bill directs the Secretary of Agriculture, in consultation with HHS, to develop common standards of identity for both cell-cultivated and plant-based alternative protein products within 180 days, aligning with the new definitions established in the Act.